Estrogen receptor
From Proteopedia
(Difference between revisions)
Line 35: | Line 35: | ||
**[[1uom]], [[2ayr]], [[2q70]], [[2qe4]], [[2pog]], [[2r6w]], [[2r6y]], [[2qxs]], [[5u2b]], [[5tn9]], [[5tnb]] - hERα LBD (mutant) + ligand<br /> | **[[1uom]], [[2ayr]], [[2q70]], [[2qe4]], [[2pog]], [[2r6w]], [[2r6y]], [[2qxs]], [[5u2b]], [[5tn9]], [[5tnb]] - hERα LBD (mutant) + ligand<br /> | ||
**[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa]], [[5t92]], [[5t97]] - hERα LBD + ligand<br /> | **[[1err]], [[3ert]], [[1sj0]], [[1yim]], [[1r5k]], [[1xp1]], [[1xp6]], [[1xp9]], [[1xpc]], [[1xqc]], [[1yin]], [[2ouz]], [[2iog]], [[2iok]], [[3dt3]], [[3os8]], [[3os9]], [[3osa]], [[5t92]], [[5t97]] - hERα LBD + ligand<br /> | ||
+ | **[[4xi3]] - hERα LBD + bazedoxifene<br /> | ||
**[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]] - hERα LBD + peptide antagonist<br /> | **[[2bj4]], [[2jf9]], [[2jfa]], [[1pcg]] - hERα LBD + peptide antagonist<br /> | ||
**[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | **[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | ||
+ | **[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | ||
**[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | **[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | ||
**[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | **[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | ||
Line 49: | Line 51: | ||
**[[2yja]] - hERα LBD + NCAO2 peptide<br /> | **[[2yja]] - hERα LBD + NCAO2 peptide<br /> | ||
**[[5hyr]], [[5dx3]], [[5dxb]] - hERα LBD (mutant) + NCAO2 peptide + estradiol<br /> | **[[5hyr]], [[5dx3]], [[5dxb]] - hERα LBD (mutant) + NCAO2 peptide + estradiol<br /> | ||
- | **[[ | + | **[[5dxb]] - hERα LBD (mutant) + NCAO2 peptide + stilbestrol derivative<br /> |
+ | **[[4zn7]] - hERα LBD + NCAO2 peptide + benzylidene estrone<br /> | ||
**[[5kri]], [[5krj]], [[5krk]], [[5krl]], [[5krm]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | **[[5kri]], [[5krj]], [[5krk]], [[5krl]], [[5krm]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | ||
**[[5egv]], [[ehj]], [[5ei1]], [[5eit]], [[5dxk]], [[5dxe]], [[5dxg]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | **[[5egv]], [[ehj]], [[5ei1]], [[5eit]], [[5dxk]], [[5dxe]], [[5dxg]], [[5kro]] - hERα LBD (mutant) + NCAO2 peptide + anti-hormone<br /> | ||
Line 89: | Line 92: | ||
**[[2yly]] - hERβ LBD + sulfonamide agonist<br /> | **[[2yly]] - hERβ LBD + sulfonamide agonist<br /> | ||
**[[2fsz]] - hERβ LBD (mutant) + ligand<br /> | **[[2fsz]] - hERβ LBD (mutant) + ligand<br /> | ||
- | **[[2yja]], [[2yjd]] - hERβ LBD + | + | **[[2yja]], [[2yjd]] - hERβ LBD + NCAO peptide<br /> |
+ | **[[4zi1]] - hERβ LBD + NCAO5 peptide + antagonist<br /> | ||
**[[4j24]], [[4j26]] - hERβ LBD + peptide<br /> | **[[4j24]], [[4j26]] - hERβ LBD + peptide<br /> | ||
Revision as of 09:37, 9 May 2017
|
For more details see
Ivan Koutsopatriy estrogen receptor
C-di-GMP receptors with PilZ domain
For more details on ERβ see Student Project 10 for UMass Chemistry 423 Spring 2015
For more details on ER-Tamoxifen complex see Tamoxifen.
3D structures of estrogen receptor
Updated on 09-May-2017
Reference
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y